gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE American · CPHIHealthcarePharmaceuticals

China Pharma Holdings, Inc. (CPHI)

$0.5875−3.56%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$0.59▼ 62.19% in range
Nov 4, 2025Low $0.52 · High $8.10Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

China Pharma Holdings closed at $0.59 on Nov 4, down 3.56%, 92.7% below its 52-week closing high. Volume of 32.8K shares was 0.01× its 20-day average (below normal).

Split-adjusted performance: -8.4% over one month, +11.4% over six months.

In the quarter ended Jun 30, 2026, revenue was $948.34K, down 7.5% from a year earlier, with a net margin of -153.8%.

Short interest was 198.3K shares at the Oct 15 settlement, up 220.5% from the prior report (10.1% of float, 1.0 days to cover).

Market cap$25.3M43.0M shares
Revenue · quarter$948.3K−7.5% YoY
Diluted EPS$-0.04—
P/E · TTM—P/S 6.5×
Net margin-153.8%Gross 8.8%
Dividend yieldNone
52-week range0.52 – 8.10−92.7% from high
Volume32.8K0.01× 20-day avg
Volatility · 60d90.2%Annualised
Short % of float10.1%1.0 days to cover
Net cash-$3.3MCash $304.9K
Next earnings—Not scheduled
Split-adjusted performance
1W −5.2%1M −8.4%3M −51.4%6M +11.4%YTD −51.4%1Y —3Y −88.5%5Y −99.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum77
Revenue growth35
Net margin41
Value (low P/E)—
Size23

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short198.3K+220.5% vs prior
Days to cover1.0Settled Oct 15
% of float10.1%
Short vol. 10d36.0%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CPHIChina Pharma Holdings$0.5875−3.56%+11.4%−7.5%−153.8%—$25.3M
SHPHShuttle Pharmaceuticals Holdings$5.21+1.17%−33.2%———$24.8MCompare
CELUCelularity$0.8088−1.02%−13.0%−5.3%10.1%—$26.2MCompare
ABVCABVC BioPharma$1.00+1.51%−9.1%———$26.7MCompare
NXTCNextCure$5.85−1.02%−45.4%———$26.8MCompare
CRVOCervoMed$1.56+0.65%−59.3%−100.0%——$23.6MCompare
RNAZTransCode Therapeutics$1.60+1.91%−78.7%———$27.1MCompare
MIRAMIRA Pharmaceuticals$0.5610+8.34%−43.9%———$23.6MCompare
AARDAardvark Therapeutics$1.26+2.44%−78.6%———$27.6MCompare

News about China Pharma Holdings

All news →

No recent articles focused on China Pharma Holdings.

Quick answers

What does China Pharma Holdings do?
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China.
What is CPHI's market cap?
$25.28M, based on the Nov 4 close of $0.59.
Does China Pharma Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CPHI is sold short?
198.3K shares, 10.1% of float, as of Oct 15, 2026.
What sector is CPHI in?
Healthcare, in the Pharmaceuticals industry.

About China Pharma Holdings

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

HQ: Hainan Province, F4221 employeesListed Apr 14, 2002chinapharmaholdings.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology